HealthCare Royalty Partners
28
45M
18
1.65
11
0.32
13
- Stages of investment
- Areas of investment
Summary
HealthCare Royalty Partners appeared to be the VC, which was created in 2007. The leading representative office of defined VC is situated in the Stamford. The company was established in North America in United States.
Deals in the range of 10 - 50 millions dollars are the general things for fund. Comparing to the other companies, this HealthCare Royalty Partners performs on 0 percentage points less the average number of lead investments. The fund is constantly included in less than 2 deals per year. The higher amount of exits for fund were in 2017. The high activity for fund was in 2014. Despite it in 2019 the fund had an activity. Speaking about the real fund results, this VC is 30 percentage points more often commits exit comparing to other organizations.
We can highlight the next thriving fund investment areas, such as Health Care, Biopharma. Among the most popular portfolio startups of the fund, we may highlight AcuFocus, Nuron Biotech, Cardiorentis. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has specific favorite in a number of founders of portfolio startups.
The overall number of key employees were 6.
The typical case for the fund is to invest in rounds with 2-3 participants. Despite the HealthCare Royalty Partners, startups are often financed by Quaker BioVentures, Kleiner Perkins, Helix Ventures. The meaningful sponsors for the fund in investment in the same round are Versant Ventures, Valence Life Sciences, The Carlyle Group. In the next rounds fund is usually obtained by SV Health Investors, Essex Woodlands Healthcare Partners, Wellington Management.
Investments analytics
Analytics
- Total investments
- 28
- Lead investments
- 11
- Exits
- 13
- Rounds per year
- 1.65
- Follow on index
- 0.32
- Investments by industry
- Biotechnology (21)
- Health Care (19)
- Medical (13)
- Medical Device (13)
- Therapeutics (11) Show 9 more
- Investments by region
-
- United States (26)
- Switzerland (1)
- Peak activity year
- 2014
- Number of Unicorns
- 1
- Number of Decacorns
- 1
- Number of Minotaurs
- 4
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 17
- Avg. valuation at time of investment
- 132M
- Group Appearance index
- 0.46
- Avg. company exit year
- 14
- Avg. multiplicator
- 1.32
- Strategy success index
- 0.60
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Suneva Medical | 09 Jan 2014 | Health Care, Hospital, Medical Device, Medical | Early Stage Venture | 20M | United States, California, San Diego |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.